ViiV

Description:
Juluca is ViiV Healthcare’s first 2-drug regimen, once-daily, single-pill that combines the integrase strand transfer inhibitor (INSTI) dolutegravir, with the non-nucleoside reverse transcriptase inhibitor (NNRTI) rilpivirine.

Triumeq is a once-daily single-pill dolutegravir-based regimen, containing the booster-free integrase strand transfer inhibitor (INSTI) dolutegravir and the nucleoside reverse transcriptase inhibitors (NRTIs) abacavir and lamivudine, which can be conveniently taken with or without food and may be taken at any time of day.

And my role was supporting E-mail application, Banner storyboard and Testimonial page designs.

Agency:
McCANN Echo

​Job Description:
Graphic Design

Client:
ViiV

Period:
2017 AUG

© 2004-2019 by Sean Woncheol Lee